Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/85.2
Name: Drug, bio-affecting and body treating compositions > Lymphokine > Interleukin
Description: Subject matter in which the immune mediator is a macrophage derived factor that promotes short term proliferation of T cells (IL1) or a lymphocyte derived factor that promotes long term proliferation of T cells in culture (IL2).

Patents under this class:

Patent Number Title Of Patent Date Issued
6921530 Low dose IL-2 for potentiation of immunity Jul. 26, 2005
6919206 Medium containing flt3 ligand for culturing hematophoietic cells Jul. 19, 2005
6913903 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same Jul. 5, 2005
6913924 Population of interferon producing cells Jul. 5, 2005
6906030 Carbon-substituted diketopiperazine delivery systems Jun. 14, 2005
6906170 Anti-inflammatory peptides derived from IL-2 and analogues thereof Jun. 14, 2005
6899869 Method of preparing an animal model for interstitial pneumonia May. 31, 2005
6896879 Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture May. 24, 2005
6896880 Method for treating a disease associated with excessive osteoclast formation May. 24, 2005
6892140 Immunogenic cancer peptides and uses thereof May. 10, 2005
6887461 Method of using IL-11 for treating mucositis May. 3, 2005
6849263 Pharmaceutical compositions for buccal delivery of pain relief medications Feb. 1, 2005
6843987 Mammalian cytokines; receptors; related reagents and methods Jan. 18, 2005
6841160 Meningococcal vaccines formulated with interleukin-12 Jan. 11, 2005
6838081 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient Jan. 4, 2005
6838433 IL-6 antagonist peptides Jan. 4, 2005
6805857 Method of modulating factor D, factor H and CD4 cell immune response with a polystyrene sulfonate, alginate, and saline infusion solution Oct. 19, 2004
6803036 Use of cytokines, cells and mitogens to inhibit graft versus host disease Oct. 12, 2004
6800280 Methods for treating HIV-infected patients by the administration of GM-CSF and a protease inhibitor Oct. 5, 2004
6797263 Compositions and methods for achieving immune suppression Sep. 28, 2004
6797267 Use of cytokines and mitogens to inhibit pathological immune responses Sep. 28, 2004
6793919 Methods for treating rheumatoid arthritis using IL-17 antagonists Sep. 21, 2004
6787132 Combined chemo-immunotherapy with liposomal drugs and cytokines Sep. 7, 2004
6770272 Treatment of diabetes Aug. 3, 2004
6759035 Method to prevent graft rejection using TGF-beta to induce T suppressor cells Jul. 6, 2004
6753166 IL-1 eta DNA and polypeptides Jun. 22, 2004
6749847 Hybrid cytokine of IL-7 and .beta.-chain of hepatocyte growth factor Jun. 15, 2004
6746669 Method for down-regulating IL5 activity Jun. 8, 2004
6746670 Regulatory T cells; methods Jun. 8, 2004
6737513 Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same May. 18, 2004
6733764 Immunostimulator anti-cancer compounds and methods for their use in the treatment of cancer May. 11, 2004
6730303 Fused G-CSF and IL-3 proteins and uses thereof May. 4, 2004
6723314 Use of interleukin-11 to treat gastrointestinal disorders Apr. 20, 2004
6723832 Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof Apr. 20, 2004
6719969 Treatment of liver disease and injury with CXC chemokines Apr. 13, 2004
6716422 Vaccine adjuvants for immunotherapy of melanoma Apr. 6, 2004
6713053 Use of IL-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular Mar. 30, 2004
6709658 Pneumococcal vaccines formulated with interleukin-12 Mar. 23, 2004
6709661 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis Mar. 23, 2004
6706261 Compositions and methods comprising immunogenic muteins of interleukin-6 Mar. 16, 2004
6706264 Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y Mar. 16, 2004
6706708 Cytotoxic agents comprising taxanes and their therapeutic use Mar. 16, 2004
6699466 IL-16 antagonist peptides and DNA encoding the peptides Mar. 2, 2004
6699467 Compounds and compositions for delivering active agents Mar. 2, 2004
6689353 Stabilized interleukin 2 Feb. 10, 2004
6689755 Method of stabilizing biologically active substances Feb. 10, 2004
6685930 Methods and substances for recruiting therapeutic agents to solid tumors Feb. 3, 2004
6685931 Treatment of hepatitis C virus infections with interleukin-10 Feb. 3, 2004
6685932 Coiled-coil dimer derived antagonists of 4-helix bundle cytokines, design and uses thereof Feb. 3, 2004
6683046 Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto Jan. 27, 2004

  Recently Added Patents
Predictive time entry for workforce management systems
Method for identifying bacteria in a sample
Blended block copolymer composition
System for targeted delivery of therapeutic agents
Vectorization of program code
Electric power steering apparatus
  Randomly Featured Patents
Template incision device
Handling and planting plants
Remote larger effective area optical fiber
Flame spray powder mix
Reversible thermal recording medium
Digital camera, camera main body and method for processing signal
Drawer fronts
Valve unit for controlling the delivery of a combustible gas
Disc wheel for passenger car
Mechanism for manipulating the distal end of a biomedical device